|
|
|
|
Myelofibrosis
Life hangs in balance Mar 7, 2006
North Shore Times, Zyl in good spirits. The 44-year-old mother of three suffers from the bone marrow disorder myelofibrosis. Her plight began five ...
Longtime principal Carl Fisher dies at age 82 Jan 11, 2006
Daily Breeze, He even began a second career in property management before succumbing to the effects of myelofibrosis, a disease of the bone marrow. ...
Celgene Corporation Reviews Recent Highlights and Outlines 2006 ... Jan 9, 2006
PR Newswire (press release), Phase II Hematology and Oncology Clinical Programs * Initiate Potential Regulatory Studies in CC-4047 in Sickle Cell Anemia and Myelofibrosis * Complete CC ...
AMG 531 increases platelets in patients with immune ... Jan 8, 2006
Xagena.it, 1 ). Additionally, there was one reported case of diffuse reticulin formation in the bone marrow reported as myelofibrosis. Reticulin ...
Family rallies to help mom fight rare disease Dec 27, 2005
Daytona Beach News-Journal, ...diagnosis. She was suffering from three rare diseases -- Myeloproliferative disorder, Myelodysplastic syndrome and myelofibrosis. ...
REVLIMID(R) Clinical Results as Oral Treatment Regimen in ... Dec 13, 2005
PR Newswire (press release), 13 /PRNewswire-FirstCall/ -- Celgene Corporation (NASDAQ: CELG) announced that clinical data from a REVLIMID (lenalidomide) study in myelofibrosis (MF) were ...
REVLIMID(R) Clinical Results as Oral Treatment Regimen in ... Dec 13, 2005
Yahoo! News (press release) PRNewswire-FirstCall/ -- Celgene Corporation (Nasdaq: CELG - News) announced that clinical data from a REVLIMID (lenalidomide) study in myelofibrosis (MF) were ...
REVLIMID Clinical Results as Oral Treatment Regimen in ... Dec 13, 2005
PharmaLive.com (press release), December 13, 2005 /PRNewswire-FirstCall/ -- Celgene Corporation announced that clinical data from a REVLIMID (lenalidomide) study in myelofibrosis (MF) were ...
Efficacy of Revlimid in patients with myelofibrosis Dec 13, 2005
Xagena.it, A Phase II study evaluated Revlimid ( Lenalidomide ) in previously treated patients with myelofibrosis, a rare blood disorder that can be fatal if untreated. ...
Revlimid (Lenalidomide) Clinical Results as Oral Treatment Regimen ... Dec 13, 2005
DG News ATLANTA, GA -- December 13, 2005 -- Celgene Corporation announced that clinical data from a Revlimid (lenalidomide) study in myelofibrosis (MF) were reported ...
Discoveries Reveal Gene Mutation That Causes Blood Disorders Dec 11, 2005
PR Newswire (press release), ...of blood cells. The three main MPDs are polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis. The actual incidence ...
Researchers Closer to Understanding How One Mutation Causes Three ... Dec 19, 2005
Howard Hughes Medical Institute, ...platelets. And the third, myelofibrosis, stems from abnormal growth of fibroblast cells, making the bone marrow abnormally dense. ...
Source: Quest Diagnostics Incorporated Dec 9, 2005
Yahoo! News (press release) ...abnormality in myeloproliferative diseases involving blood cells derived from bone marrow (polycythemia vera, essential thrombocythemia, and myelofibrosis). ...
Interim Long-Term Follow-up Data Show AMG 531 Increases Platelets ... Dec 12, 2005
Business Wire (press release), ...n=1); and vaginal hemorrhage (n=1). Additionally, there was one reported case of diffuse reticulin formation in the bone marrow reported as myelofibrosis. ...
Benefit supper, raffles will aid Dan 'The Lottery Man' Boggs with ... Oct 18, 2005
Missouri Valley Times News, Sunday, October 16, from 1 - 5 pm, a benefit will be held to help raise funds for the Dan Boggs Family to help with their fight against Myelofibrosis, a rare ...
Beep to join lawsuit on cleanup of creek Nov 7, 2005
New York Daily News, Some of the plaintiffs say their relatives have died of cancer. Former Hausman St. resident, Marcella Geist, 74, died of myelofibrosis, a rare cancer, in 2004. ...
Myelofibrosis is the gradual replacement of the bone marrow by connective tissue. Its main feature is "extramedullary hematopoeisis", i.e. the blood-forming cells migrate to other sites in the body, e.g. the liver or spleen. Typically affects patients > 50 years. Patients will typically have hepatosplenomegaly, and the blood smear will show "teardrop cells".
|
|
|
